Contact us

Adamas Pharmaceuticals presents positive clinical data for ADS-5102

ADAMAS PHARMACEUTICALS PRESENTS POSITIVE CLINICAL DATA FOR ADS-5102, A TREATMENT FOR LEVODOPA-INDUCED DYSKINESIA, AT THE WORLD PARKINSON’S CONGRESS

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now
  • en
  • cn

    • English

    • English
    • Chinese

    © 2021- edbi. All rights reserved.